|4May 24, 4:53 PM ET

Brady Todd C 4

4 · Evoke Pharma Inc · Filed May 24, 2024

Insider Transaction Report

Form 4
Period: 2024-05-22
Brady Todd C
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-22+14,62514,625 total
    Exercise: $0.45Exp: 2034-05-21Common Stock (14,625 underlying)
Footnotes (1)
  • [F1]The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4